18 Aug 2010
Carbidopa-Levodopa SR 50 mg-200 mg Tab--- SUSTAINED-RELEASE - ORAL / Sustained release dosage forms are designed to release a drug at a predetermined rate by maintaining a constant drug level for a specific period of time with minimum side effects.
Levodopa and carbidopa are used in combination to treat the symptoms of Parkinson's disease or Parkinson-like symptoms (e.g., shakiness, stiffness, difficulty moving). Parkinson's disease is thought to be caused by too little of a naturally occurring substance (dopamine) in the brain. Levodopa changes into dopamine in the brain, helping to control movement.Carbidopa prevents the breakdown of levodopa in the bloodstream so more levodopa can enter the brain. This can reduce some of levodopa's side effects such as nausea and vomiting, and it may also allow your doctor to increase your levodopa dose more quickly to find the best dose for you. This combination may be used alone or with other drugs for Parkinson's disease.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
... speaking ability has dramatically declined in the last 3 yrs. It is difficult to chew food with or without dentures in place and also swallowing. ...
It warns not to use with MAOI medications.
... 40mg, buspirone 10mg, remeron 30mg, trazo-done 100mg, amantadine 100mg, hydroco/acetamin 5/500mg, amlodipine 10mg, methocarbam 750mg